Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?

by A. Tincani, I. Cavazzana, A. Ceribelli, M. Fredi, F. Inverardi, M. Taraborelli, F. Franceschini
Published 2012-12-01

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

by M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani
Published 2016-12-01

Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

by P. Airò, R. Gorla, M. Vianelli, M. Frassi, E. Danieli, F. Franceschini, I. Cavazzana, R. Cattaneo
Published 2011-09-01

TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

by R. Cattaneo, R. Caporali, A. Ceribelli, S. Zingarelli, E. Bravi, C. Bazzani, F. Bobbio-Pallavicini, I. Cavazzana, F. Franceschini, C. Montecucco
Published 2011-09-01

Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center

by F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò
Published 2018-07-01

Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies

by M. Frassi, A. Brucato, I. Cavazzana, F. Franceschini, D. Faden, M. Motta, A. Doria, R. Cimaz, M.P. Pisoni, M. Muscarà, G. Castellino, G. Brambilla, P.L. Meroni, R. Cattaneo, C. Biasini Rebaioli, C. Antonioli, G. Balestrieri, A. Tincani
Published 2001-12-01